Zymeworks (NYSE:ZYME) will install Ken Galbraith as chairman and CEO, replacing the company’s outgoing leader Ali Tehrani on or before February 1. Galbraith has more than 30 years of experience working in life sciences, venture capital and global commercialization. “Ken Galbraith is an outstanding global leader who brings more than 30 years of life science…